Hanne Bersvendsen

Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by The Nordic Lymphoma Group

Elisa Jacobsen Pulczynski, Outi Kuittinen, Martin Erlanson et al. · Haematologica · 2014 · 110 citations · Full text

Medicine, Geriatric Medicine, Oncology +13

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

Emanuele Zucca, Stéphanie Rondeau, Anna Vanazzi et al. · Blood · 2019 · 60 citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin’s lymphoma; symptom burden and quality of life

Siri A. Eikeland, Knut B. Smeland, Floortje Mols et al. · Acta Oncologica · 2021 · 38 citations · Full text

Medicine, Neurology, Oncology +10

Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation

Cecilie E. Kiserud, U-M. Fagerli, Knut B. Smeland et al. · Acta Oncologica · 2016 · 28 citations · Full text

Medicine, Oncology, Cell Therapy +8

Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes

Hanne Bersvendsen, Hege Sagstuen Haugnes, Unn-Merete Fagerli et al. · Acta Oncologica · 2019 · 21 citations · Full text

Pharmacy, Health Behavior, Oncology +17